Terms: = Bone cancer AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Diagnosis
80 results:
1. Insights into IGH clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications.
Darzentas F; Szczepanowski M; Kotrová M; Hartmann A; Beder T; Gökbuget N; Schwartz S; Bastian L; Baldus CD; Pál K; Darzentas N; Brüggemann M
Front Immunol; 2023; 14():1125017. PubMed ID: 37143651
[TBL] [Abstract] [Full Text] [Related]
2. Myeloid sarcoma in a newborn: A rare manifestation of congenital acute myeloid leukemia.
Mullen B; Sabet K; Jacobs S; Calleroz AT; Habeshian KA; Cheng J
Pediatr Dermatol; 2023; 40(4):751-752. PubMed ID: 37029447
[TBL] [Abstract] [Full Text] [Related]
3. Partial tandem duplication of kmt2a gene in patient afflicted with hypereosinophilic syndrome: A case report.
Ghasemian Sorbeni F; Ansarin A; Sakhinia E; Montazersaheb S
Cancer Genet; 2022 Nov; 268-269():111-114. PubMed ID: 36288642
[TBL] [Abstract] [Full Text] [Related]
4. High frequency of heat shock protein 27 overexpression is a highly effective, high-coverage marker for minimal residual disease detection in children with B-cell acute lymphoblastic leukemia.
Chou SW; Su YH; Lu MY; Chang HH; Yang YL; Lin DT; Lin KH; Coustan-Smith E; Jou ST
Pediatr Blood Cancer; 2023 Jan; 70(1):e29990. PubMed ID: 36250996
[TBL] [Abstract] [Full Text] [Related]
5. Rat prostate tumors induce DNA synthesis in remote organs.
Halin Bergström S; Lundholm M; Nordstrand A; Bergh A
Sci Rep; 2022 May; 12(1):7908. PubMed ID: 35551231
[TBL] [Abstract] [Full Text] [Related]
6. bone Marrow Surveillance of Pediatric cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia.
Spitzer B; Rutherford KD; Gundem G; McGovern EM; Millard NE; Arango Ossa JE; Cheung IY; Gao T; Levine MF; Zhang Y; Medina-Martínez JS; Feng Y; Ptashkin RN; Bolton KL; Farnoud N; Zhou Y; Patel MA; Asimomitis G; Cobbs CC; Mohibullah N; Huberman KH; Arcilla ME; Kushner BH; Modak S; Kung AL; Zehir A; Levine RL; Armstrong SA; Cheung NKV; Papaemmanuil E
Clin Cancer Res; 2022 Apr; 28(8):1614-1627. PubMed ID: 35078859
[TBL] [Abstract] [Full Text] [Related]
7. 'I Can't Keep Up!': an update on advances in soft tissue pathology occurring after the publication of the 2020 World Health Organization classification of soft tissue and bone tumours.
Folpe AL
Histopathology; 2022 Jan; 80(1):54-75. PubMed ID: 34958510
[TBL] [Abstract] [Full Text] [Related]
8. Minimal residual disease and outcome characteristics in infant kmt2a-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol.
Stutterheim J; de Lorenzo P; van der Sluis IM; Alten J; Ancliffe P; Attarbaschi A; Aversa L; Boer JM; Biondi A; Brethon B; Diaz P; Cazzaniga G; Escherich G; Ferster A; Kotecha RS; Lausen B; Leung AW; Locatelli F; Silverman L; Stary J; Szczepanski T; van der Velden VHJ; Vora A; Zuna J; Schrappe M; Valsecchi MG; Pieters R
Eur J Cancer; 2022 Jan; 160():72-79. PubMed ID: 34785111
[TBL] [Abstract] [Full Text] [Related]
9. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and kmt2a-rearranged AML.
Menghrajani K; Gomez-Arteaga A; Madero-Marroquin R; Zhang MJ; Bo-Subait K; Sanchez J; Wang HL; Aljurf M; Assal A; Bacher VU; Badawy SM; Bejanyan N; Bhatt VR; Bredeson C; Byrne M; Castillo P; Cerny J; Chhabra S; Ciurea SO; DeFilipp Z; Farhadfar N; Gadalla S; Gale RP; Ganguly S; Gowda L; Grunwald MR; Hashmi S; Hildebrandt G; Kanakry CG; Kansagra A; Khimani F; Krem M; Lazarus H; Liu H; Martino R; Michelis FV; Nathan S; Nishihori T; Olsson R; Reshef R; Rizzieri D; Rowe JM; Savani BN; Seo S; Sharma A; Solh M; Ustun C; Verdonck LF; Hourigan C; Sandmaier B; Litzow M; Kebriaei P; Weisdorf D; Zhang Y; Tallman MS; Saber W
Blood Adv; 2022 Jan; 6(3):828-847. PubMed ID: 34551064
[TBL] [Abstract] [Full Text] [Related]
10. Therapy-induced Deletion in 11q23 Leading to Fusion of
Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897
[TBL] [Abstract] [Full Text] [Related]
11. Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature.
Liao C; Hu NX; Song H; Zhang JY; Shen DY; Xu XJ; Tang YM
Int J Hematol; 2021 May; 113(5):751-759. PubMed ID: 33392975
[TBL] [Abstract] [Full Text] [Related]
12.
Kato S; Kubota Y; Sekiguchi M; Watanabe K; Shinozaki-Ushiku A; Takita J; Hiwatari M
Pediatr Hematol Oncol; 2021 Apr; 38(3):281-289. PubMed ID: 33150819
[No Abstract] [Full Text] [Related]
13. Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia.
Moskop A; Pommert L; Thakrar P; Talano J; Phelan R
Pediatr Blood Cancer; 2021 Jan; 68(1):e28739. PubMed ID: 33009894
[TBL] [Abstract] [Full Text] [Related]
14. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis.
Hill HA; Qi X; Jain P; Nomie K; Wang Y; Zhou S; Wang ML
Blood Adv; 2020 Jul; 4(13):2927-2938. PubMed ID: 32598477
[TBL] [Abstract] [Full Text] [Related]
15. Secondary acquisition of BCR-ABL1 fusion in de novo GATA2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare kmt2a-ASXL2 fusion.
Blackburn PR; Huang L; Dalovisio A; Pitel BA; Chen D; Oliveira JL; Wood AJ; Smadbeck JB; Johnson SH; Vasmatzis G; Haferlach C; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Peterson JF
Cancer Genet; 2020 Feb; 241():67-71. PubMed ID: 31902694
[TBL] [Abstract] [Full Text] [Related]
16. Improved Outcomes of Childhood Acute Lymphoblastic Leukemia: A Retrospective Single Center Study in Saudi Arabia.
Ahmed AM; Al-Trabolsi H; Bayoumy M; Abosoudah I; Yassin F
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3391-3398. PubMed ID: 31759364
[TBL] [Abstract] [Full Text] [Related]
17. Genetic alteration patterns and clinical outcomes of elderly and secondary acute myeloid leukemia.
Wang SY; Cheng WY; Mao YF; Zhu YM; Liu FJ; Ma TT; Shen Y
Hematol Oncol; 2019 Oct; 37(4):456-463. PubMed ID: 31348835
[TBL] [Abstract] [Full Text] [Related]
18. Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive CML patient undergoing treatment with dasatinib.
Janjetovic S; Asemissen AM; Dicker F; Binder M; Dierlamm J; Bokemeyer C; Schafhausen P
Tumori; 2019 Dec; 105(6):NP8-NP11. PubMed ID: 30935343
[TBL] [Abstract] [Full Text] [Related]
19. Rare myeloid sarcoma with kmt2a (mll)-ELL fusion presenting as a vaginal wall mass.
Bao H; Gao J; Chen YH; Altman JK; Frankfurt O; Wilson AL; Sukhanova M; Chen Q; Lu X
Diagn Pathol; 2019 Mar; 14(1):26. PubMed ID: 30922345
[TBL] [Abstract] [Full Text] [Related]
20.
Wang YM; Mo JQ; Kuo DJ; Wong V
BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30772833
[TBL] [Abstract] [Full Text] [Related]
[Next]
